Tested Applications
| Positive WB detected in | mouse liver tissue, HepG2 cells, mouse lung tissue, rat liver tissue |
| Positive IHC detected in | human liver tissue, human liver cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:2000-1:10000 |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
21721-1-AP targets CYP2A6 in WB, IHC, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human, mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag16377 Product name: Recombinant human CYP2A6 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 198-494 aa of BC096253 Sequence: FLSLLRMMLGIFQFTSTSTGQLYEMFSSVMKHLPGPQQQAFQLLQGLEDFIAKKVEHNQRTLDPNSPRDFIDSFLIRMQEEEKNPNTEFYLKNLVMTTLNLFIGGTETVSTTLRYGFLLLMKHPEVEAKVHEEIDRVIGKNRQPKFEDRAKMPYMEAVIHEIQRFGDVIPMSLARRVKKDTKFRDFFLPKGTEVYPMLGSVLRDPSFFSNPQDFNPQHFLNEKGQFKKSDAFVPFSIGKRNCFGEGLARMELFLFFTTVMQNFRLKSSQSPKDIDVSPKHVGFATIPRNYTMSFLPR Predict reactive species |
| Full Name | cytochrome P450, family 2, subfamily A, polypeptide 6 |
| Calculated Molecular Weight | 494 aa, 57 kDa |
| Observed Molecular Weight | 50 kDa |
| GenBank Accession Number | BC096253 |
| Gene Symbol | CYP2A6 |
| Gene ID (NCBI) | 1548 |
| RRID | AB_10791886 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | P11509 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for CYP2A6 antibody 21721-1-AP | Download protocol |
| WB protocol for CYP2A6 antibody 21721-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The anti-CYP2A6 antibody (Cat# 21721-1-AP) has 8 total citations across 7 unique publications. Citations appear in Acta Pharmacologica Sinica, Biochemical Pharmacology, Frontiers in Nutrition, Frontiers in Toxicology, Scientific Reports, Biochemical and Biophysical Research Communications, and Xenobiotica. Research fields span hepatocellular carcinoma, colon cancer drug resistance, renal fibrosis, atherosclerosis, neuroinflammation, breast cancer circadian biology, and cytochrome P450 drug metabolism.
| Species | Application | Title |
|---|---|---|
Acta Pharmacol Sin CYP2A6 suppresses hepatocellular carcinoma via inhibiting SRC/Wnt/β-Catenin pathway | ||
Biochem Pharmacol Drug resistance induces the upregulation of H2S-producing enzymes in HCT116 colon cancer cells. | ||
Front Nutr Asiatic acid from Centella asiatica alleviates renal fibrosis: coordinated modulation of the gut-kidney axis and retinol metabolism. | ||
Front Toxicol E-cigarette exposure causes early pro-atherogenic changes in an inducible murine model of atherosclerosis | ||
Sci Rep Extracellular vesicles released from macrophages modulates interleukin-1β in astrocytic and neuronal cells | ||
Biochem Biophys Res Commun Circadian rhythms in CYP2A5 expression underlie the time-dependent effect of tegafur on breast cancer |













